Bluejay Therapeutics logo

Bluejay Therapeutics

0 followers

About Bluejay Therapeutics

Bluejay Therapeutics is a private biopharmaceutical company that specializes in developing curative treatments for viral infections and liver diseases, including CHB and CHD.

Recent News

Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, for Up To $820M

Fed Rate Cut Tailwind, Lilly’s Triple Agonist Delivers Big, Vaccine Policy Turmoil — This Week in Biotech #81

Mirum Acquires Bluejay, Adding Brelovitug Treatment for HDV

Recent Deals

Mirum Pharmaceuticals to Acquire Bluejay Therapeutics for Up to $820M

December 9, 2025

Mirum Pharmaceuticals Acquires Bluejay Therapeutics, Adding Brelovitug for HDV

January 26, 2026